Preview

Антибиотики и Химиотерапия

Расширенный поиск

Бактериальный вагиноз и трихомониаз: ведущие мировые руководства по тактике ведения и принципах терапии таких пациентов

Полный текст:

Аннотация

Синдром вагинальных выделений - одна из самых частых причин обращения женщин к врачу. Чаще всего с выделениями из влагалища ассоциируют 3 заболевания: бактериальный вагиноз, трихомониаз и кандидоз. В обзоре рассматриваются современные подходы к лечению пациенток с бактериальным вагинозом и трихомониазом, разными по этиологии и патогенезу, но в то же время схожими в плане терапии заболеваниями. Анализ проведён согласно принципам, изложенным в двух ведущих мировых руководствах.

Об авторе

М. А. Гомберг
МГМСУ им. А.И. Евдокимова; Московский научно-практический центр дерматовенерологии и косметологии
Россия


Список литературы

1. Centers for Disease Control and Prevention. Diseases Characterized by Vaginal Discharge. MMWR 2010; 59: 12: 56-63

2. Sherrard J., Donders G., White D., Skov Jensen J.S. European (IUSTI/WHO) guideline on the management of vaginal discharge. Int J STD AIDS 22: 8: 421-429.

3. Hale L.P., Swidsinski A., Mendling W. Bacteria associated with bacterial vaginosis. N Engl J Med 2006; 354: 202-203.

4. Oliveira F.A., Pfleger V., Lang K. et al. Sexually transmitted infections, bacterial vaginosis, and candidiasis in women of reproductive age in rural North-East Brazil: a population-based study. Mem Inst Oswaldo Cruz. 2007; 102 (6): 751-756.

5. Fang X., Zhou Y., Yang Y., Diao Y., Li H. Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis for married women of child-bearing age in rural Shandong. Jpn J Infect Dis 2007; 60 (5): 257-261.

6. Koumans E.H., Sternberg M., Bruce C. et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34 (11): 864-869.

7. Dan M., Kaneti N., Levin D., Poch F., Samra Z. Vaginitis in a gynecologic practice in Israel: causes and risk factors. Isr Med Assoc J 2003; 5 (9): 629-632.

8. Bickley L.S., Krisher K.K., Punsalang A. et al. Comparison of direct fluorescent antibody, acridine orange, wet mount and culture for detection of Trichomonas vaginalis in women attending a public sexually transmitted disease clinic. Sex Trans Dis 1989; 127-131.

9. Gelbart S.M., Thomason J.L., Osypowski et al. Growth of Trichomonas vaginalis in commercial culture media. J. Clin. Microbiol 1990; 28, 962-964.

10. Madico G., Quinn T.C., Rompalo A. et al. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36: 3205-3210.

11. Crucitti T., Van Dyck E., Tehe A. et al. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in selfcollected swab specimens. Sex Transm Infect 2003; 79: 393-398.

12. Landers D.V., Wiesenfeld H.C., Heine R.P. et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004; 190 (4): 1004-1010.

13. Amsel R., Totten P.A., Spiegel C.A. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74 (1): 14-22.

14. Ison C.A., Hay P.E. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm. Infect 2002; 78 (6): 413-415.

15. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29 (2): 297-301.

16. Oduyebo O.O., Anorlu R.I., Ogunsola F.T. The effects of antimicrobial therapy on bacterial vaginosis in nonpregnant women. Cochrane Database Syst Rev 2009; 3: CD006055.

17. Schindler E.M., Thamm H., Ansmann E.B. et al. Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparison with metronidazole. Fortschr Med 1991; 109 (5): 138-140.

18. Voorspoels J., Casteels M., Remon J.P., Temmerman M. Local treatment of bacterial vaginosis with a bioadhesive metronidazole tablet. Eur J Obstet Gynecol Reprod Biol 2002; 105 (1): 64-66.

19. Hanson J.M., McGregor J.A., Hillier S.L. et al. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med 2000; 45 (11): 889-896.

20. Brandt M., Abels C., May T. et al. Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects. Eur J Obstet Gynecol Reprod Biol 2008; 141 (2): 158-162.

21. Paavonen J., Mangioni C., Martin M.A., Wajszczuk C.P. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol 2000; 96 (2): 256-260.

22. Mikamo H., Kawazoe K., Izumi K. Comparative study on vaginal or oral treatment of bacterial vaginosis. Chemotherapy 1997; 43 (1): 60-68.

23. Schwebke J.R., Desmond R.A. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 2007; 44 (2): 213-219.

24. Schwebke J.R., Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol 2007; 196: 517-516.

25. Das S., Huegnsberg M., Shahmanesh M. Treatment failure of vaginal tri-chomonisis in clinical practice. Intl J STD & AIDS. 2005; 16: 284-286.

26. Crowell A.L., Sanders-Lewis K.A., Secor W.E. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrobial Agents and Chemotherapy 2003; 47: 1407-1409.

27. Sobel J.D., Nyirjesy P., Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clinical Infectious Diseases 2001; 33: 1341-1346.

28. Mannen-Tobin A., Wilson J.D. Management of metronidazole-resistant Trichomonas vaginalis - a new approach. Intl J STD & AIDS 2005; 16: 488-490.

29. Sobel J.D., Ferris D., Schwebke J. et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194 (5): 1283-1289.

30. Marcone V., Calzolari E., Bertini M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol 2008; 31 (3): 429-433.

31. Simoes J.A., Bahamondes L.G., Camargo R.P. et al. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol 2006; 61 (2): 211-217.

32. Kissinger P., Schmidt N., Mohammed H. et al. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis 2006; 33: 445-450.

33. Schwebke J.R., Desmond R.A. A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women. Sex Transm Dis 2010; 37: 392-396.

34. Lyng J., Christensen J. A double blind study of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand 1981; 60: 199-201.

35. Dykers J.R. Single dose metronidazole treatment for trichomonal vaginitis - patient and consort. N Eng J Med 1975; 293; 23-24.

36. Klebanoff M.A., Carey J.C., Hauth J.C. et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345: 487-493.

37. Kigozi G.G., Brahmbhatt H., Wabwire-Mangen F. et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2003; 189: 1398-1400.

38. Burtin P., Taddio A., Adburnu O. et al. Safety of metronidazole in pregnancy: a metaanalysis. Am J Obstet Gynecol 1995; 172: 525-529.

39. Czeizel A.E., Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998; 105: 322-327.

40. Caro-Paton T., Carvajal A., de Diego I.M. et al. Is metronidazole teratogenic: a meta-analysis. Br J Clin Pharmacol 1997; 44: 179-182.

41. Burtin P., Taddio A., Ariburnu O. et al. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172: 2 (1): 525-529.

42. Piper J.M., Mitchel E.F., Ray W.A. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993; 82: 348-352.

43. Ugwumadu A., Reid F., Hay P. et al. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol 2004; 104: 114-119.

44. Hauth J.C., Goldenberg R.L., Andrews W.W. et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732-1736.

45. Morales W.J., Schorr S., Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994; 171: 345-347.

46. Kurohara M.L., Kwong F.K., Lebherz T.B., Klaustermeyer W.B. Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol 1991; 88: 279-280.

47. Pearlman M. D., Yashar C., Ernst S. et al. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole. Am J Obstet Gynecol 1996; 174: 934-936.

48. Helms D.J., Mosure D.J., Secor W.E. et al. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol 2008; 198: 370-377.

49. Schmid G., Narcisi E., Mosure D. et al. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001; 46: 545-549.

50. Schwebke J.R., Barrientes F.J. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006; 50: 4209-4210.

51. Падейская Е.H. 5-Нитроимидазолы - антимикробные препараты для лечения бактериальных и протозойных инфекций. Consilium-Midicum 2004; 6: 1.


Для цитирования:


Гомберг М.А. Бактериальный вагиноз и трихомониаз: ведущие мировые руководства по тактике ведения и принципах терапии таких пациентов. Антибиотики и Химиотерапия. 2013;58(1-2):19-26.

For citation:


Gomberg M.A. Bacterial Vaginosis and Trichomononiasis. Fundamental World Guidelines on Management and Therapy of the Patients. Antibiotics and Chemotherapy. 2013;58(1-2):19-26. (In Russ.)

Просмотров: 46


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0235-2990 (Print)